EP4724433A2 - Psychoaktive arzneimittel und ihre verwendung zur behandlung psychiatrischer und neurologischer erkrankungen und störungen - Google Patents

Psychoaktive arzneimittel und ihre verwendung zur behandlung psychiatrischer und neurologischer erkrankungen und störungen

Info

Publication number
EP4724433A2
EP4724433A2 EP24819953.1A EP24819953A EP4724433A2 EP 4724433 A2 EP4724433 A2 EP 4724433A2 EP 24819953 A EP24819953 A EP 24819953A EP 4724433 A2 EP4724433 A2 EP 4724433A2
Authority
EP
European Patent Office
Prior art keywords
methylone
subject
disorder
neuropsychiatric illness
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24819953.1A
Other languages
English (en)
French (fr)
Inventor
Blake MANDELL
Martin Stogniew
Jennifer Louise SCHMIDT
Markus SEELIG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transcend Therapeutics Inc
Original Assignee
Transcend Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transcend Therapeutics Inc filed Critical Transcend Therapeutics Inc
Priority claimed from PCT/US2024/032615 external-priority patent/WO2024254190A2/en
Publication of EP4724433A2 publication Critical patent/EP4724433A2/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
EP24819953.1A 2023-06-06 2024-06-05 Psychoaktive arzneimittel und ihre verwendung zur behandlung psychiatrischer und neurologischer erkrankungen und störungen Pending EP4724433A2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202363471412P 2023-06-06 2023-06-06
US202363602904P 2023-11-27 2023-11-27
US202363605729P 2023-12-04 2023-12-04
US202363607702P 2023-12-08 2023-12-08
US202463553788P 2024-02-15 2024-02-15
US202463649653P 2024-05-20 2024-05-20
PCT/US2024/032615 WO2024254190A2 (en) 2023-06-06 2024-06-05 Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders

Publications (1)

Publication Number Publication Date
EP4724433A2 true EP4724433A2 (de) 2026-04-15

Family

ID=98099691

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24819953.1A Pending EP4724433A2 (de) 2023-06-06 2024-06-05 Psychoaktive arzneimittel und ihre verwendung zur behandlung psychiatrischer und neurologischer erkrankungen und störungen

Country Status (5)

Country Link
EP (1) EP4724433A2 (de)
KR (1) KR20260053276A (de)
AU (1) AU2024284688A1 (de)
IL (1) IL324918A (de)
MX (1) MX2025014366A (de)

Also Published As

Publication number Publication date
AU2024284688A1 (en) 2025-12-11
MX2025014366A (es) 2026-02-03
IL324918A (en) 2026-01-01
KR20260053276A (ko) 2026-04-21

Similar Documents

Publication Publication Date Title
JP2025036702A (ja) 神経認知障害、慢性疼痛を治療し、炎症を低減させる方法
US11969407B2 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
TWI553006B (zh) 依託拉嗪(eltoprazine)於治療與神經或心理疾病有關之認知失能之症狀的用途
US12295937B2 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
US20220265582A1 (en) Effects of mescaline and of mescaline analogs (scalines) to assist psychotherapy
WO2023191952A1 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
US12343326B2 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
US20260130884A1 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
US20250332139A1 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
AU2024284688A1 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
WO2024254190A2 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
US20250221957A1 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
HK40120411A (zh) 精神作用药物及其用於治疗精神和神经病状和病症的用途
HK40112015A (zh) 精神作用药物及其用於治疗精神和神经病状和病症的用途
CN118434416A (zh) 精神作用药物及其用于治疗精神和神经病状和病症的用途
HK40068315A (en) Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
WO2026068388A1 (en) Ghrelin o-acyl transferase (goat) inhibitors for use in the treatment of substance use disorder in patients with high impulsivity

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20260106

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: TRANSCEND THERAPEUTICS, INC.